|
| View:
Latest News | Top Stories |
|
| Saturday, Nov 7, 2009 |
|
| · | [external] Genmab to cut 130 jobs in Brooklyn Park, sell biotech factory
at bizjournals.com -
Sat 2:05 pm ET |
|
| · | DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations
Business Wire -
Sat 7:00 am ET |
|
| Friday, Nov 6, 2009 |
|
| · | Money-Making Mood Stabilizers
at CNBC -
Fri 9:46 pm ET |
|
| · | Halozyme Study Results Demonstrate Significantly Less Absorption Variability for Insulin Lispro Administered with PH20 Enzyme
Business Wire -
Fri 9:00 pm ET |
|
| · | GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010
Business Wire -
Fri 8:15 pm ET |
|
| · | Cramer's 8 Picks for Cancer's Cure
at CNBC -
Fri 7:58 pm ET |
|
| · | [video] Battling Cancer
at CNBC -
Fri 6:45 pm ET |
|
| · | [external] Cramer's 'Mad Money' Recap: Next Week's Game Plan (Update 2)
at TheStreet.com -
Fri 6:32 pm ET |
|
| · | [external] Philips: Managing Flux
at Forbes.com -
Fri 6:00 pm ET |
|
| · | [external] ZymoGenetics says restraining orders lifted
at bizjournals.com -
Fri 5:05 pm ET |
|
| · | Celgene Corporation to Present at Two Upcoming Investor Conferences
Business Wire -
Fri 4:30 pm ET |
|
| · | Stull, Stull & Brody Announces Investigation on Behalf of Shareholders of Trimeris, Inc.
Business Wire -
Fri 3:09 pm ET |
|
| · | Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2010 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST
GlobeNewswire -
Fri 3:06 pm ET |
|
| · | Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript
at Seeking Alpha -
Fri 2:59 pm ET |
|
| · | [external] Biotech Stocks: Drug stocks edge higher; Alkermes slides
at MarketWatch -
Fri 2:38 pm ET |
|
| · | Aastrom Biosciences Reports First Quarter Fiscal Year 2010 Financial Results
GlobeNewswire -
Fri 1:30 pm ET |
|
| · | Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
PR Newswire -
Fri 1:00 pm ET |
|
| · | CEL-SCI's L.E.A.P.S. H1N1 Flu Development Seen as Credibility Booster
Business Wire -
Fri 12:34 pm ET |
|
| · | [external] GTC Biotherapeutics: Cash will dry up in Q1 without new revenue sources
at bizjournals.com -
Fri 12:05 pm ET |
|
| · | Halozyme takes bigger loss on testing expenses
AP -
Fri 11:21 am ET |
|
|
More Latest News...
|
